Blood magnesium concentration and dopamine or dobutamine infusion demand in patients during CABG (Coronary artery bypass grafting) with normovolemic haemodilution

Magnesium Research

Volumn 19, Issue 4, 2006, Pages 261-267

  Pasternak, K ^a   Wronska J ^a   Dabrowski, W ^a   Sztanke, M ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

CABG; Dobutamine; Dopamine; Extracorporeal circulation; Magnesium

Indexed keywords

CARDIOTONIC AGENT; DOBUTAMINE; DOPAMINE; MAGNESIUM;

AGED; ARTICLE; BLOOD; BLOOD VOLUME; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; HEMODILUTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED;

AGED; BLOOD VOLUME; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; DOBUTAMINE; DOPAMINE; EXTRACORPOREAL CIRCULATION; HEMODILUTION; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM; MALE; MIDDLE AGED;

ANGINA;

EID: 33847689848     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: 10.1684/mrh.2006.0070     Document Type: Article

References (31)

1. Haigney MCP, Silver B, Tanglao E, Silverman HS, Hill JD, Shapiro E, Gerstenblith G, Schulman SP. Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation 1995; 92: 2190-7.
2. Agus ZS. Hypomagnesemia. J Am Soc Nephrol 1999; 10: 1616-22.
3. Nair RR, Nair P. Alteration of myocardial mechanics in marginal magnesium deficiency. Magnes Res 2002; 15: 287-306.
4. Caspi J, Rudis E, Bar I, Safadi T, Saute M. Effects of magnesium on myocardial function after coronary artery bypass grafting. Ann Thorac Surg 1995; 59: 942-7.
5. Ravn HB, Moeldrup U, Brookers CIO, Ilkjaer LB, White P, Chew M, Jensen L, Johensen S, Brik-Soerensen L, Hjortdal VE. Intravenous magnesium reduces infarct size after ischemia/reperfusion injury combined with a thrombogenic lesion in the left anterior descending artery. Arterioscler Thromb Vasc Biol 1999; 19: 569-74.
6. Christensen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administrated before but not after coronary reperfusion in a canine model. Circulation 1995; 92: 2617-21.
7. Pasternak K, Da̧browki W, Wyciszczok T, Korycińska A, Dobija J, Biernacka J, Rzecki Z. The relationship between magnesium, epinephrine and norepinephrine blood concentrations during CABG with normovolemic haemodilution. Magnes Res 2005; 18: 245-52.
8. Cavaliere F, Sciarra M, Zamparelli R, Monaco C, Bonifazi S, Schavello R. Magnesium metabolism in open heart surgery. Resuscitation 1986; 13: 215-21.
9. Inoue S, Akazawa S, Nakaigawa Y, Shimizu R, Seo N. Changes in plasma total and ionized magnesium concentrations and factors affecting magnesium concentrations during cardiac surgery. J Anesth 2004; 18: 216-9.
10. Booth JV, Phillips-Bute B, McCants CB, Podgoreanu MV, Smith PK, Mathew PJ, Newman MF. Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass graft surgery. Am Heart J 2003; 145: 1108-13.
11. Parra L, Fita G, Gomar C, Rovira I, Marin JL. Plasma magnesium in patients submitted to cardiac surgery: its influence on perioperative morbidity. J Cardiovasc Surg (Torino) 2001; 42: 37-42.
12. Shiga T, Wajima Z, Inoue T, Ogawa R. Magnesium prophylaxis for arrhythmias after cardiac surgery: a metaanalysis of randomized controlled trials. Am J Med 2004; 117: 325-33.
13. Zaman AG, AlagmirF, Richens T, Williams R, Rothman MT, Mills PG. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart 1997; 77: 527.
14. Ceremuzynski L, Gebalska J, Wolk R, Makowska E. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Intern Med 2000; 247: 78-86.
15. Dube L, Granry JC. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can JAnesth 2003; 50: 732-46.
16. Ralston MA, Murnane MR, Unverferth DV, Leier CV. Serum and tissue magnesium concentrations in patients with failure and serious ventricular arrhythmias. Ann Intern Med 1990; 113: 841-6.
17. Sommers KE, Ohkado A, Simplaceanu E, Koretsky AP, Ho C, del Nido PJ. The role of magnesium in postischemic cardiac dysfunction. Surgery 1992; 112: 159-65.
18. Howarth FC, Waring J, Hustler BI, Singh J. Effects of extracellular magnesium and beta adrenergic stimulation on contractile force and magnesium mobilization in the isolated rat heart. Magnes Res 1994; 7: 187-97.
19. +2 concentration in isolated rat hearts via beta-adrenergic and muscarinic receptors. J Moll Cell Cardiol 1998; 30: 2307-18.
20. Colucci WS, Sawyer DB, Singh K, Communal C. Adrenergic overload and apoptosis in heart failure: implications for therapy. J Card Fail 2000; 6: 1-7.
21. Dostanic S, Servant N, Wang C, Chalifour L. E. Chronic β-adrenoreceptor stimulation in vivo decreased Bcl-2 and increased Bax expression but did not activate apoptotic pathways in mouse heart. Can J Physiol Pharmacol 2004; 82: 167-74.
22. Antman EM. Magnesium in acute MI. Circulation 1995; 92: 2367-72.
23. Herzog WR, Scholssberg ML, MacMurdy KS, Edenbaum LR, Gerber MJ, Vogel RA, Serebruany VL. Timing of magnesium therapy affects experimental infarct size. Circulation 1995; 92: 2622-6.
24. Vigorito C, Giordano A, Ferraro P, Acanfora D, De Caprio L, Naddeo C, Rengo F. Hemodynamic effects of magnesium sulfate on the normal human heart. Am J Cardiol 1991; 67: 1435-7.
25. Dickens BF, Weglicki WB, Li YS, Mak IT. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 1992; 311: 187-91.
26. du Toit EF, Opie LH. Modulation of severity of reperfusion stunning in isolated rat heart by agents altering calcium flux at reperfusion. Cric Res 1992; 70: 960-7.
27. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD investigators. Circulation 1996; 94: 690-7.
28. Banfi C, Cavalca V, Veglia F, Brioschi M, Barcella S, Mussoni L, Boccotti L, Tremoli E, Biglioli P, Agostini P. Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure. Eur Heart J 2005; 26: 481-8.
29. Michailova AP, Belik ME, McCulloch AD. Effects of magnesium on cardiac excitation-contraction coupling. J Am Coll Nutr 2004; 23: 514S-517S.
30. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion injury, a clinical view on a complex pathophysiological process. Int J Cardiol 2005; 100: 179-90.
31. Au-Yeung KK, Zhu DY, OK Slow YL. Inhibition of stress-activated protein kinase in the ischemic/reperfused heart: role of magnesium tanshinoate B in preventing apoptosis. Biochem Pharmacol 2001; 15: 483-93.